No statistically significant differences between benign and malignant thyroid tumors were observed in the expression levels of Drp1; however, when we considered in our analysis only the oncocytic tumors, Drp1 expression levels were higher in carcinomas than in adenomas. Here, DNM1L is linked to adenoma.